1. Prophylactic Dendritic Cell Vaccination in Experimental Breast Cancer Controls Immunity and Hepatic Metastases
- Author
-
Márcia Antoniazi Michelin, Jéssica Ferreira Vieira, Eddie Fernando Candido Murta, and Ana Paula Peixoto
- Subjects
Cancer Research ,Helper T lymphocyte ,medicine.medical_treatment ,Breast Neoplasms ,Cancer Vaccines ,T-Lymphocytes, Regulatory ,Mice ,Immune system ,Bone Marrow ,Biomarkers, Tumor ,Animals ,Medicine ,Cytotoxic T cell ,IL-2 receptor ,Mice, Inbred BALB C ,business.industry ,Liver Neoplasms ,Vaccination ,Immunity ,FOXP3 ,Dendritic Cells ,General Medicine ,Immunotherapy ,Dendritic cell ,Disease Models, Animal ,Liver ,Oncology ,Cancer research ,Female ,business ,CD8 ,T-Lymphocytes, Cytotoxic - Abstract
BACKGROUND/AIM Liver metastases are among the principal mortality causes in cancer patients. Dendritic cell immunotherapies have shown promising results in some tumors by mediating immunological mechanisms that could be involved in liver metastases during primary tumor growth. The present study aimed to evaluate the impact of prophylactic dendritic cell vaccination on the liver of mice with 4T1 mouse breast carcinoma. MATERIALS AND METHODS Adult female Balb/c mice were submitted or not to vaccination with dendritic cells before the induction of 4T1 tumor lineage. Liver tissues from mice were analyzed by flow cytometry (markers CD3, CD4, CD8, CD25, IL-10, IL-12, IL-17, TNF-α, IFN-γ, T-bet, GATA3, RORγt, and FoxP3) and hematoxylin-eosin. The dendritic cell vaccine was differentiated and matured ex vivo from the bone marrow. RESULTS Prophylactic vaccination reduced areas of liver metastases (p=0.0049), induced an increase in the percentage of total T and cytotoxic T lymphocytes (p
- Published
- 2021